Advanced Analytics with Spark: Patterns for Learning from Data at Scale

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.

whitePaper | February 8, 2023

For centuries, patients have sought medical help for their ailments. Just as in the past, however, there are still many illnesses – both wellknown, widespread diseases and rare conditions – that initially cause few or inconclusive symptoms, and many patients leave the doctor’s office with an incorrect diagnosis. In addition, diseases may progress slowly or quickly depending on the individual.

whitePaper | August 20, 2021

While finding and creating insights can often feel like luck, there are proven methodologies you can use to ensure you’re seeing regular insight from your on-hand data. Access this short e-book to learn how you can start seeing regular, valuable insight success from you big data and analytics investments.

whitePaper | August 1, 2022

The Graph database is fundamental to driving a much-needed breakthrough in the world of Master Data Management (MDM). Until now, traditional MDM systems have imposed strict rules and structures on how these projects are managed. This has cost enterprises dearly in terms of wasted time and resources and has been a major contributory factor to the failure of many MDM initiatives. Graph has changed all of that, allowing modern MDM platforms to completely redefine how master data is prepared for insight and used to deliver tangible business outcomes.

whitePaper | September 12, 2022

This whitepaper examines clinical trial data contribution policies and the data protection methodologies applied to protect patient privacy. Information published by 29 biopharma sponsors was collected across three data-sharing platforms, collated by sponsor size. Results showed that large sponsor contribution policies can provide helpful benchmarks for medium and smaller sponsors.

whitePaper | August 9, 2022

Data virtualization helps organizations access data across disparate sources and deliver a unified view of the data faster, cheaper, and using fewer resources than traditional data integration approaches. In this TEI, data virtualization delivered 83% reduction in time-torevenue and 65% decrease in delivery times over extract, transform, and load (ETL) processes.